A concerning health alert has prompted the Food and Drug Authority (FDA) to warn the public and urge vigilance.
The Authority, in a statement dated April 2, indicated that it has discovered falsified HIV diagnostic kits being sold in the Ghanaian market, particularly the VISITECT CD4 Advanced Disease test kits used to measure CD4 cell counts in patients with advanced HIV disease.
According to the FDA, there are some counterfeit test kits of the VISITECT CD4 Advanced Disease test kits with lot number 0001586. They do not meet the required safety standards, hence the need for the public to stay away from them.
How to identify the fake kits
The FDA also pointed out that the counterfeit kits wrongly list Omega Diagnostics Limited as the manufacturer, whereas the genuine VISITECT CD4 kits are produced by AccuBio Limited.
In addition, authentic VISITECT kits have unique lot numbers, unlike the fake kits that show 0002172, and they include proper product details.
The Authority also pointed out clear inconsistencies in the dates printed on the products. It said the falsified kits show incorrect manufacturing dates as well.
“The Food and Drugs Authority has discovered falsified VISITECT CD4 Advanced Disease test kits on the Ghanaian market. These counterfeit products, bearing lot number 0001586 and wrongly listing Omega Diagnostics Limited as the manufacturer, pose a serious threat to public health. The genuine kits are produced by AccuBio Limited with lot number 0002172. The public and healthcare providers are advised to exercise vigilance and report suspicious products immediately,” the statement indicated.

The FDA noted that such differences in manufacturer information and dates should serve as warning signs. It advised healthcare providers to pay close attention to these details when handling medical products.
The FDA warned that the presence of these kits in our markets poses serious risks to public health, consequently warning that wrong results could delay treatment for people living with HIV or cause unnecessary fear for those who receive false-positive outcomes.
“Your health is too important to risk,” the FDA stated, calling for increased vigilance across the health sector.
FDA response
As part of immediate measures, the Authority has directed all hospitals, laboratories, and testing centres to check their stock of VISITECT CD4 test kits. It warned that any kits with lot number 0001586 must be removed from use at once.
The FDA further instructed that such products should be returned to the nearest FDA office for proper disposal.
It also encouraged both health professionals and the public to report any suspected fake medical products through its official channels.
The Authority said it has begun investigations to trace the source of the falsified kits and ensure those responsible are held accountable. It also urged the public to verify medical products before use to avoid potential harm.
Meanwhile, statistics from the AIDS Commission revealed that over three hundred and thirty-four thousand (334,000) Ghanaians were living with Human Immunodeficiency Virus (HIV).
According to a statement issued on Monday, December 1, Ghana recorded 12,600 AIDS-related deaths in 2024 and over 15,200 new infections.
Last month, the Commission disclosed alarming statistics regarding the number of individuals living with HIV in the Bono Region. Speaking during the inauguration of the Bono Regional Committee of the Ghana AIDS Commission (RECCOM) in Sunyani on Thursday, November 20, the Regional Technical Coordinator, Ahmed Ibrahim Bambila, revealed that 19,979 residents in the Bono Region are living with HIV and AIDS.
According to him, 875 new HIV infections have been recorded, highlighting an urgent need for attention and immediate action.
44 persosn contract HIV daily
The Ghana AIDS Commission revealed that an average of 42 new HIV (Human Immunodeficiency Virus) infections were recorded daily among adults and children across the country.
According to the Commission’s 2024 National and Sub-National HIV Estimates and Projections, a total of 334,721 people were living with HIV in Ghana. Out of this figure, 105,460 were males, representing 31.5 percent, while 229,261 were females, accounting for 68.5 percent.
The Bono, Bono East, and Ahafo Regional Technical Coordinator of the GAC, Mr. Ahmed Ibrahim Bimbilla, who disclosed this in an interview with the Ghana News Agency (GNA) in Sunyani, said the data provided crucial insight into the scale of the epidemic and guided effective planning.
He revealed that 15,290 new HIV infections were recorded in the country, comprising 4,987 males, representing 32.6 percent, and 10,303 females, representing 67.4 percent.
Mr. Bimbilla also noted that AIDS-related deaths stood at 12,614, consisting of 5,445 males and 7,159 females. He said approximately 229 deaths were prevented each week through the provision of Antiretroviral Therapy (ART) services.
Providing a regional breakdown, he said the North East Region recorded the lowest HIV population with 1,717 cases, while Greater Accra, Ashanti, and Eastern recorded the highest figures of 77,821, 63,159, and 44,792, respectively.
He added that seven regions, Ahafo, Upper East, Northern, Upper West, Oti, Savannah, and North East, each recorded HIV populations below 10,000.
According to him, HIV prevalence was highest in the Bono Region with 2.22 percent, followed by the Eastern Region with 2.08 percent and Ahafo with 1.88 percent, while the North East Region recorded the lowest prevalence at 0.43 percent.
He further indicated that five regions, Oti, Upper East, Savannah, Northern, and North East, recorded prevalence rates below 1.0 percent. Mr Bimbilla stated that the Greater Accra, Ashanti, and Eastern regions also recorded the highest number of new HIV infections, with 3,436, 2,997, and 2,019 cases, respectively. In comparison, the North East Region recorded the fewest cases, with 97.
Eleven regions, including Bono, Volta, Bono East, Western North, Ahafo, Upper East, Northern, Upper West, Oti, Savannah, and North East, recorded fewer than 1,000 new infections.
Commenting on the trend, Mr. Bimbilla described the decline in HIV prevalence, new infections, and AIDS-related deaths as a positive development, which he attributed to the growing uptake of ART services.
He expressed optimism that the downward trend would help Ghana achieve epidemic control and urged continued efforts in public education, testing, and access to treatment to sustain progress toward eliminating HIV and AIDS.



































